相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RIPK1 and Caspase-8 Ensure Chromosome Stability Independently of Their Role in Cell Death and Inflammation
Gianmaria Liccardi et al.
MOLECULAR CELL (2019)
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
Stefanie Jilg et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
A new option for remission induction in acute myeloid leukaemia
Carsten Mueller-Tidow et al.
LANCET ONCOLOGY (2018)
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile
Veronika Reidel et al.
Oncotarget (2018)
Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies
Courtney D. DiNardo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Bcl-xL mediates RIPK3-dependent necrosis in M. tuberculosis-infected macrophages
X. Zhao et al.
MUCOSAL IMMUNOLOGY (2017)
PLK1, A Potential Target for Cancer Therapy
Zhixian Liu et al.
TRANSLATIONAL ONCOLOGY (2017)
Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients
S. Jilg et al.
LEUKEMIA (2016)
Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
Rosie Elizabeth Ann Gutteridge et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with acute myeloid leukemia
Yukio Kobayashi et al.
CANCER SCIENCE (2015)
Inhibition of polo like kinase 1 in sarcomas induces apoptosis that is dependent on Mcl-1 suppression
Jayasree S. Nair et al.
CELL CYCLE (2015)
Efficacy and Mechanism of Action of Volasertib, a Potent and Selective Inhibitor of Polo-Like Kinases, in Preclinical Models of Acute Myeloid Leukemia
Dorothea Rudolph et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
Hartmut Doehner et al.
BLOOD (2014)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure
Thomas Prebet et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cells
Annelies G. Renner et al.
BLOOD (2009)
BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity
Dorothea Rudolph et al.
CLINICAL CANCER RESEARCH (2009)
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Pierre Fenaux et al.
LANCET ONCOLOGY (2009)
A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies
T. Ikezoe et al.
LEUKEMIA (2009)
Mechanisms of Disease: Myelodysplastic Syndromes.
Ayalew Tefferi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Polo-Like Kinase (PLK) Inhibitors in Preclinical and Early Clinical Development in Oncology
Patrick Schoffski
ONCOLOGIST (2009)
Polo-like kinase 1 expression is a prognostic factor in human colon cancer
Wilko Weichert et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Polo-like kinase isoforms in breast cancer:: expression patterns and prognostic implications
W Weichert et al.
VIRCHOWS ARCHIV (2005)
Overexpression of polo-like kinase 1 is a common and early event in pancreatic cancer
W Weichert et al.
PANCREATOLOGY (2005)
Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma
W Weichert et al.
BRITISH JOURNAL OF CANCER (2004)
Polo-like kinase I is overexpressed in prostate cancer and linked to higher tumor grades
W Weichert et al.
PROSTATE (2004)
Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation
D Nijhawan et al.
GENES & DEVELOPMENT (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome
CW Lin et al.
LEUKEMIA RESEARCH (2002)
Selective localization of Bcl-2 to the inner mitochondrial and smooth endoplasmic reticulum membranes in mammalian cells
T Gotow et al.
CELL DEATH AND DIFFERENTIATION (2000)
分享论文
